HGH FRAGMENT 176-191

All the information below is strictly for research purposes only. Under no circumstance should this chemical be used for human consumption.

·       Formula: C78H125N23O23S2

·       Molecular weight: 1817.12

·       Peptide purity: > 99.0%

·       Chain:H-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH

Fragment 176-191, or Frag 176-191, is a variant part of an amino acid sequence known as G-Hormone. It contains properties of both hormones and petptides and has a molecular mass of 1817.12. The formula is C78H125N23O23S2.

Research on this compound began in the late 70s when scientists working with similar proteins were able to get a handle on their physical structure and functions. It was hypothesized in 1978 that the functionality of such proteins was linked to the configuration the same as to the informational sequence. In 1984, further research showed that Frag 176-191 was rich in proline and possessed features including high levels of proteases. It was also discovered that accessibility was the cause of alterations and binding of the proteins in certain regions.
 

Frag 176-191 has been studied to affect the adipose fat tissue or cells by increasing lipolitic activity. It is a modified amino acid sequence of G-hormone.
With a molecular weight of 1871.1 its molecular formula is C78H125N23O23S2. Frag 176-191 is a HG-hormone fragment 176-191, being a variant part of an amino acid sequence known as G-hormone. Research beginning in the 1970’s on similar proteins, Frag 176-191 showed properties of being rich in proline and high levels of proteases in 1984 clinical research. While showing some properties of G-hormones, Fragment 176-191 was determined to not cause hyperglycemia or negative changes in the level of glucose in the blood. Laboratory testing and research have shown that the HGH fragment 176-191 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis (the transformation of nonfat food materials into body fat).

Hgh fragment 176-191  is a stabilized analogue of the growth hormone-releasing factor (GRF) that induces Growth Hormone in a specific and physiological manner. To date, studies suggest that HGH Fragment 176-191 has several beneficial features: it reduces abdominal fat in particular visceral fat, without compromising glycemic control (blood glucose), it increases muscle mass and improves the lipid profile.

Studies that can be found easily show that at a dosage of 500mcg, HGH Fragment 176-191 was shown to increase lipolytic activity in adipose tissue ,this HGH Fragment potently burns body fat, especially stubborn adipose body fat, and at the same time as it doesnt spike glucose levels, or cause any problems with insulin sensitivity, and improving your lipid profile, this really should be part of any dedicated athletes fat loss regime.
Unlike GH, HGH fragment doesnt induce cell proliferation, it does not induce hyperglycaemia or reduce insulin secretion. HGH fragment 176-191 does not compete for the HGH receptor, but of important note is the HGH Fragment’s ability to increase IGF-1 levels which translate into the HGH Fragment’s ability to give collateral anti-aging and anabolic effects along with its ability to induce fat loss in the most stubborn body fat (adipose tissue) while increasing energy expenditure and glucose and fat oxidation.

Frag 176-191 is a fragment of amino acids 176-191 of at the C-Terminous end of the hGH, human growth hormone. The small region of the GH molecule at the C-Terminal region is referred to as Frag 176-191 and is being researched for its ability to reduce adipose fat tissue. Studies are looking into this fragment of GH as the part that triggers lipolysis which increases lipogenesis without negatively effecting insulin resistance or endogenous GH.